Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01239368
What this trial is testing

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-MultipleMyelomatosis
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00586014
What this trial is testing

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 91
Testing effectiveness (Phase 2)Ended earlyNCT00053014
What this trial is testing

S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 5
Testing effectiveness (Phase 2)Study completedNCT01283776
What this trial is testing

Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation

Who this might be right for
Multiple MyelomaNon-Hodgkin-LymphomaHodgkin's Disease
University of Cologne 11
Not applicableNot Yet RecruitingNCT06245018
What this trial is testing

A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor

Who this might be right for
Solid Tumor
Nuwacell Biotechnologies Co., Ltd. 50
Not applicableNot Yet RecruitingNCT07034755
What this trial is testing

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Chimeric Antigen Receptor T-cell
The Affiliated Hospital of Xuzhou Medical University 20
Post-approval studies (Phase 4)Study completedNCT00616135
What this trial is testing

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastMammaplasty+1 more
Cytori Therapeutics 71
Testing effectiveness (Phase 2)Study completedNCT01175785
What this trial is testing

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Nohla Therapeutics, Inc. 15
Early research (Phase 1)Looking for participantsNCT07664176
What this trial is testing

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

Who this might be right for
Diffuse Midline Glioma or Diffuse Intrinsic Pontine GliomaHigh Grade GliomasMedulloblastoma Recurrent+3 more
Children's National Research Institute 30
Very early researchWithdrawnNCT05104268
What this trial is testing

Study of a New Medical Device for Oral Mucositis

Who this might be right for
Oral MucositisStem Cell Transplant Complications
E2Bio Life Sciences, LLC
Testing effectiveness (Phase 2)Looking for participantsNCT05632380
What this trial is testing

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492050
What this trial is testing

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT02955550
What this trial is testing

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Celularity Incorporated 15
Testing effectiveness (Phase 2)Study completedNCT01010880
What this trial is testing

Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biokine Therapeutics Ltd 16
Testing effectiveness (Phase 2)Study completedNCT00925821
What this trial is testing

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wuerzburg University Hospital 146
Not applicableEnded earlyNCT04270604
What this trial is testing

Biological Sample Collection for Research and Biobanking

Who this might be right for
Parkinson DiseaseDiabetes Mellitus, Type 1Macular Degeneration+4 more
New York Stem Cell Foundation Research Institute 1,279
Testing effectiveness (Phase 2)Study completedNCT00559104
What this trial is testing

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 60
Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Testing effectiveness (Phase 2)Ended earlyNCT01235793
What this trial is testing

The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma

Who this might be right for
B-Cell Lymphoma Originating in the CNS
Cedars-Sinai Medical Center 11
Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Next Page